Search
for
Sort by
Research 61–90 of 1000+
- Fusarium sp. Strain K-23 Alleviates Salt Stress in Arabidopsis thaliana Through its Root Hair Growth-Promoting Effect
- Anagen effluvium due to thallium poisoning derived from the intake of Chinese herbal medicine and rodenticide containing thallium salts
- The Enterobacter sp. SA187 stimulates stress-responsive genes and promotes salt and heat stress tolerance in tomato plants
- Electronic States of Epigallocatechin-3-Gallate in Water and in 1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (Sodium Salt) Liposomes
- The semiotics of breast cancer: Signs, symptoms, and sales
- Electronic States of Epigallocatechin-3-Gallate in Water and in 1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (Sodium Salt) Liposomes
- In vitro biocompatibility, antibacterial activity, and release behavior of halloysite nanotubes loaded with diclofenac sodium salt incorporated in electrospun soy protein isolate/hydroxyethyl cellulose nanofibers
- Transcriptomic profiling of Arabidopsis Thaliana responses to Stutzerimonas stutzeri, chlorella vulgaris, and mixed consortium inoculation under salt stress
- Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2
- The Interaction of Hair Fibers with Alkali Bromide Solutions
- Understanding the Effect on Hair Fibers of Coloring and Bleaching Formulations Using High Pressure Differential Scanning Calorimetry (HPDSC)
- Chemical bonds and hair behaviour—A review
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia areata: An update
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- The role of macrophages in skin homeostasis
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Pericardial Disorders Occurring During Open-Label Study of 1,869 Severely Hypertensive Patients Treated with Minoxidil
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Alefacept for Severe Alopecia Areata